11 Greenway Plaza,Suite 1000
Houston , TX, 77046-1173

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on securities and depositary receipts of foreign issuers. More

Link

Directors

Jan 13, 2023
  • Cynthia Hostetler
  • Anthony J. LaCava, Jr.
  • Elizabeth Krentzman
  • Robert C. Troccoli
  • Martin L. Flanagan
  • Eli Jones
  • Joel W. Motley
  • Daniel S. Vandivort
  • Prema Mathai-Davis
  • Teresa M. Ressel
  • Beth Ann Brown

Chief Compliance Officer

  • Todd F. Kuehl

Fund Manager(s)

Price

  • $ 11.44 ( -0 )
    Apr 24, 2023
    Last Close
  • Net Assets
  • $68.6M
    Apr 3, 2023
  • Holding
  • 62
    Apr 3, 2023
    More

  • 52-Week High/Low
  • $12.76 - $9.62
  • Turnover
  • 61%
  • Expense Ratio
  • 1.37%

Company Name

Holding

Roche Holding AG 4.26 %
TotalEnergies SE 3.39 %
AIA Group Ltd. 2.92 %
Airbus SE 2.85 %
Taiwan Semiconductor Manufacturing Co. Ltd. 2.84 %
AstraZeneca PLC 2.69 %
KDDI Corp. 2.57 %
DBS Group Holdings Ltd. 2.56 %
Nintendo Co., Ltd. 2.53 %
Tate & Lyle PLC 2.43 %
More 2.43 %

Advisor

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

33.32%

5 Year

-2.92%

Best

30.09%

2009

Worst

-39.93%

2008

Alpha

IIBRX S&P 500

Chart +